C07K 14/5425
Il-9
Official title: {il-9}
C07K14/5425 (Il-9) appears on 41 US grants and 48 published applications in this corpus.
Search patents in C07K- Granted patents
- 41
- Published applications
- 48
- Assignees
- 25
- Inventors
- 97
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 1 |
| 2003 | 2 | 3 |
| 2004 | 0 | 8 |
| 2005 | 0 | 4 |
| 2006 | 1 | 0 |
| 2007 | 5 | 0 |
| 2008 | 4 | 3 |
| 2009 | 0 | 2 |
| 2010 | 3 | 0 |
| 2011 | 2 | 2 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 2 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 4 |
| 2018 | 3 | 0 |
| 2019 | 2 | 2 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 2 | 4 |
| 2024 | 1 | 4 |
| 2025 | 1 | 4 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Heterodimeric FC cytokines and uses thereof13 Jan 2026US 12,522,639 B2Synthekine, Inc.
- Recombinant adenoviruses and uses thereof27 May 2025US 12,312,382 B2Beth Israel Deaconess Medical Center, Inc.
- Heterodimeric Fc cytokines and uses thereof1 Oct 2024US 12,103,954 B2Synthekine, Inc.
- Expression of metabolic modulators in tumor microenvironment to improve tumor therapy17 Oct 2023US 11,786,569 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Recombinant adenoviruses and uses thereof3 Oct 2023US 11,773,142 B2Beth Israel Deaconess Medical Center, Inc.
- Multispecific engineered biomolecules and uses thereof16 Jul 2026US 2026/0201007 A1The Regents of the University of California
- Therapeutic cytokines and methods8 Jan 2026US 2026/0008830 A1Fundació Centre De Regulació GenòMica
- Recombinant adenoviruses and uses thereof30 Oct 2025US 2025/0333454 A1Beth Israel Deaconess Medical Center, Inc.
- Clusterin overexpression in alzheimer’s disease11 Sep 2025US 2025/0283074 A1University of Virginia Patent Foundation
- Chimeric antigen receptor modified regulatory t cells for treating cancer24 Jul 2025US 2025/0235478 A1MUSC Foundation for Research Development
Most cited
By later US patents
- Derivatives of growth hormone and related proteins160US 6,608,183 B1Bolder Biotechnology, Inc. · 2003
- Asthma associated factors as targets for treating atopic allergies including asthma and related disorders84US 5,908,839 AMagainin Pharmaceuticals Inc. · 1999
- Cysteine variants of granulocyte-macrophage colony-stimulating factor45US 7,148,333 B2Bolder Biotechnology, Inc. · 2006
- Methods of treating asthma with interleukin-9 antibodies26US 6,261,559 B1Genaera Corporation · 2001
- Termini cysteine-added variants of granulocyte-macrophage colony stimulating factor23US 7,214,779 B2Bolder Biotechnology, Inc. · 2007